Program

All times listed in the program are in Finnish time (UTC+2).

9:00 Onsite Registration Starts, Light Breakfast Available

9:30 Welcome & Practical Information
Ouli Uimonen, CEO & Anja Isoaho, Training Manager, Pharmaca Health Intelligence
Moderator: Hanna Saari, Associate Director, Service Line Lead, Regulatory Informatics and Operations, Cencora (PharmaLex)

9:45 Updates in the Regulatory Landscape Regarding ePI (EU Pharma Legislation Update & Implementing Acts) 
Antonios Rodiadis, Policy Officer, European Commission, Directorate-General for Health and Food Safety (DG SANTE)

10:30 Break & Networking

10:50 NCA Perspective on ePI Implementation
Viltė Šilkaitytė, Chief Specialist, State Medicines Control Agency, Lithuania

11:30 ePI under the New Pharmaceutical Legislation from an Industry Perspective
Peter Mardov-Egvang, Sr Regulatory Policy Specialist, Novo Nordisk

12:00 Lunch Break & Networking

13:00 Building Trust in Medicines Information – AI, ePI and a Connected European Ecosystem
Bente Jansen, Managing Director, Felleskatalogen
Tiia Metiäinen, Associate Director, Medicines Information, Pharmaca Health Intelligence

14:00 Patient Perspective: Access to Answers
Marketta Liljeström, Specialist, Association of Cancer Patients in Finland

14:30 Coffee Break & Networking  

15:00 Panel Discussion: Preparing for the Future of ePL and ePI
Bente Jansen, Managing Director, Felleskatalogen 
Marketta Liljeström, Specialist, Association of Cancer Patients in Finland
Peter Mardov-Egvang, Sr Regulatory Policy Specialist, Novo Nordisk
Antonios Rodiadis, Policy Officer, European Commission, Directorate-General for Health and Food Safety (DG SANTE)
Viltė Šilkaitytė, Chief Specialist, State Medicines Control Agency, Lithuania

15:50–16:00 Closing Remarks
Hanna Saari, Associate Director, Service Line Lead, Regulatory Informatics and Operations, Cencora (PharmaLex)
Anja Isoaho, Training Manager, Pharmaca Health Intelligence